THOC6
THO complex subunit 6
Also known as: fSAP35, MGC2655, THOC6_HUMAN, WDR58
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86W42
- Gene
- THOC6
- Ensembl
- ENSG00000131652
- Chromosome
- 16
- Canonical length
- 341 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear speckles
OverviewNCBI Gene
This gene encodes a subunit of the multi-protein THO complex, which is involved in coordination between transcription and mRNA processing. The THO complex is a component of the TREX (transcription/export) complex, which is involved in transcription and export of mRNAs. A missense mutation in this gene is associated with a neurodevelopmental disorder called Beaulieu-Boycott-Innes syndrome. [provided by RefSeq, Dec 2016]
Canonical amino-acid sequenceUniProt
341 residues, UniProt reviewed canonical sequence.
>Q86W42|THOC6
1 MERAVPLAVP LGQTEVFQAL QRLHMTIFSQ SVSPCGKFLA AGNNYGQIAI FSLSSALSSE
61 AKEESKKPVV TFQAHDGPVY SMVSTDRHLL SAGDGEVKAW LWAEMLKKGC KELWRRQPPY
121 RTSLEVPEIN ALLLVPKENS LILAGGDCQL HTMDLETGTF TRVLRGHTDY IHCLALRERS
181 PEVLSGGEDG AVRLWDLRTA KEVQTIEVYK HEECSRPHNG RWIGCLATDS DWMVCGGGPA
241 LTLWHLRSST PTTIFPIRAP QKHVTFYQDL ILSAGQGRCV NQWQLSGELK AQVPGSSPGL
301 LSLSLNQQPA APECKVLTAA GNSCRVDVFT NLGYRAFSLS FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against THOC6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 25 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 25 nTPM
- skin: 24 nTPM
- bone marrow: 22 nTPM
- spleen: 22 nTPM
- liver: 21 nTPM
- prostate: 21 nTPM
Single-cell type
- migrating cytotrophoblasts: 152 nCPM
- extravillous trophoblasts: 144 nCPM
- cytotrophoblasts: 123 nCPM
- syncytiotrophoblasts: 81 nCPM
- esophageal basal cells: 76 nCPM
- oocytes: 65 nCPM
Immune cell
- myeloid DC: 89 nTPM
- plasmacytoid DC: 75 nTPM
- intermediate monocyte: 62 nTPM
- classical monocyte: 61 nTPM
- total PBMC: 45 nTPM
- naive B-cell: 43 nTPM
Brain region
- pons: 14 nTPM
- medulla oblongata: 11 nTPM
- thalamus: 11 nTPM
- choroid plexus: 9.5 nTPM
- cerebellum: 9.3 nTPM
- white matter: 8.8 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about THOC6.
Disease | AllUniProt
Conditions THOC6 is implicated in, by any mechanism.
- Beaulieu-Boycott-Innes syndrome (BBIS) MIM:613680
Disease | GeneticClinVar
25 pathogenic / likely-pathogenic of 141 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome
- Inborn genetic diseases
- THOC6-related disorder
- Intellectual disability
- Dystonia, early-onset, and/or spastic paraplegia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.67
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.4
- DepMap mean gene effect
- -0.41
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- central nervous system development
- mRNA export from nucleus
- mRNA processing
- RNA splicing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of THOC6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads THOC6 as an antibody target. Whether an autoantibody or antibody against THOC6 could matter depends on whether native THOC6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
THOC6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label THOC6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...